STOCK PLUMMETS AFTER NOVO NORDISK DEAL BREAKDOWN

Shares of HIMS experienced a dramatic slump today following the unexpected cancellation of its deal with pharmaceutical giant Novo Nordisk. Investors interpreted negatively to the news, sending HIMS's stock price plummeting by more than 10%. The reason for the collapse of the partnership remains unclear, but industry analysts speculate that it coul